Kelly A Avery-Kiejda

6PUBLICATIONS
10CO-AUTHORS
Predictive and prognostic markersHaematological tumoursTe ariā o ngā tauira panoni hauora o te Māori (Māori theory of change models for health)Oncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 08, 2023
p53 isoform expression promotes a stemness phenotype and inhibits doxorubicin sensitivity in breast cancer.

Luiza Steffens Reinhardt, Kira Groen, Xiajie Zhang

|Jun 28, 2023
p53 Dysregulation in Breast Cancer: Insights on Mutations in the TP53 Network and p53 Isoform Expression.

Luiza Steffens Reinhardt, Kira Groen, Alexandre Xavier

|Oct 28, 2022
Alterations in the p53 isoform ratio govern breast cancer cell fate in response to DNA damage.

Luiza Steffens Reinhardt, Xiajie Zhang, Kira Groen

|Oct 14, 2022
Evaluation of Circulating MicroRNAs and Adipokines in Breast Cancer Survivors with Arm Lymphedema.

Khairunnisa' Md Yusof, Kira Groen, Rozita Rosli

|Apr 28, 2021
Cross-Cultural Adaptation of the Functional Assessment of Cancer Therapy-Breast (FACT-B) in Malaysian Breast Cancer Survivors.

Khairunnisa' Md Yusof, Rozi Mahmud, Maha Abdullah

|Nov 16, 2018
The intron 3 16 bp duplication polymorphism of p53 (rs17878362) is not associated with increased risk of developing triple-negative breast cancer.

Brianna C Morten, Simon Chiu, Christopher Oldmeadow

Pageof 1